BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 24376686)

  • 1. EGFRvIII mediates hepatocellular carcinoma cell invasion by promoting S100 calcium binding protein A11 expression.
    Luo X; Xie H; Long X; Zhou M; Xu Z; Shi B; Jiang H; Li Z
    PLoS One; 2013; 8(12):e83332. PubMed ID: 24376686
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The monoclonal antibody CH12 enhances the sorafenib-mediated growth inhibition of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Yang Y; Jiang H; Gao H; Kong J; Zhang P; Hu S; Shi B; Zhang P; Yao M; Li Z
    Neoplasia; 2012 Jun; 14(6):509-18. PubMed ID: 22787432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of and Mechanism Underlying Autophagy in Hepatocellular Carcinoma Induced by CH12, a Monoclonal Antibody Directed Against Epidermal Growth Factor Receptor Variant III.
    Xu W; Song F; Wang B; Li K; Tian M; Yu M; Pan X; Shi B; Liu J; Gu J; Li Z; Jiang H
    Cell Physiol Biochem; 2018; 46(1):226-237. PubMed ID: 29587298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidermal growth factor receptor variant III mediates head and neck cancer cell invasion via STAT3 activation.
    Wheeler SE; Suzuki S; Thomas SM; Sen M; Leeman-Neill RJ; Chiosea SI; Kuan CT; Bigner DD; Gooding WE; Lai SY; Grandis JR
    Oncogene; 2010 Sep; 29(37):5135-45. PubMed ID: 20622897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S100A4 regulates migration and invasion in hepatocellular carcinoma HepG2 cells via NF-κB-dependent MMP-9 signal.
    Zhang J; Zhang DL; Jiao XL; Dong Q
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(17):2372-82. PubMed ID: 24065232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
    Han C; Michalopoulos GK; Wu T
    J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3 cooperates with Twist to mediate epithelial-mesenchymal transition in human hepatocellular carcinoma cells.
    Zhang C; Guo F; Xu G; Ma J; Shao F
    Oncol Rep; 2015 Apr; 33(4):1872-82. PubMed ID: 25653024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. S100A11 Promotes Metastasis via AKT and ERK Signaling Pathways and Has a Diagnostic Role in Hepatocellular Carcinoma.
    Zheng M; Meng H; Li Y; Shi J; Han Y; Zhao C; Chen J; Han J; Liang J; Chen Y; Liu Q; Wang Y
    Int J Med Sci; 2023; 20(3):318-328. PubMed ID: 36860671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JAK2/STAT3 targeted therapy suppresses tumor invasion via disruption of the EGFRvIII/JAK2/STAT3 axis and associated focal adhesion in EGFRvIII-expressing glioblastoma.
    Zheng Q; Han L; Dong Y; Tian J; Huang W; Liu Z; Jia X; Jiang T; Zhang J; Li X; Kang C; Ren H
    Neuro Oncol; 2014 Sep; 16(9):1229-43. PubMed ID: 24861878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Knockdown of LPCAT1 Repressed Hepatocellular Carcinoma Growth and Invasion by Targeting S100A11.
    Sun Q; Fu C; Liu J; Li S; Zheng J
    Ann Clin Lab Sci; 2023 Mar; 53(2):212-221. PubMed ID: 37094849
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cyclooxygenase-2 is a novel transcriptional target of the nuclear EGFR-STAT3 and EGFRvIII-STAT3 signaling axes.
    Lo HW; Cao X; Zhu H; Ali-Osman F
    Mol Cancer Res; 2010 Feb; 8(2):232-45. PubMed ID: 20145033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NCAPG2 overexpression promotes hepatocellular carcinoma proliferation and metastasis through activating the STAT3 and NF-κB/miR-188-3p pathways.
    Meng F; Zhang S; Song R; Liu Y; Wang J; Liang Y; Wang J; Han J; Song X; Lu Z; Yang G; Pan S; Li X; Liu Y; Zhou F; Wang Y; Cui Y; Zhang B; Ma K; Zhang C; Sun Y; Xin M; Liu L
    EBioMedicine; 2019 Jun; 44():237-249. PubMed ID: 31176678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis.
    Jin J; Wang SJ; Cui J; Li L; Li JY; Liu FL; Sun XX; Jiang JL; Cui HY; Chen ZN
    Cell Oncol (Dordr); 2019 Aug; 42(4):537-554. PubMed ID: 31016558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Choline Kinase α Mediates Interactions Between the Epidermal Growth Factor Receptor and Mechanistic Target of Rapamycin Complex 2 in Hepatocellular Carcinoma Cells to Promote Drug Resistance and Xenograft Tumor Progression.
    Lin XM; Hu L; Gu J; Wang RY; Li L; Tang J; Zhang BH; Yan XZ; Zhu YJ; Hu CL; Zhou WP; Li S; Liu JF; Gonzalez FJ; Wu MC; Wang HY; Chen L
    Gastroenterology; 2017 Apr; 152(5):1187-1202. PubMed ID: 28065789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LINC00997, a novel long noncoding RNA, contributes to metastasis via regulation of S100A11 in kidney renal clear cell carcinoma.
    Chang Y; Li N; Yuan W; Wang G; Wen J
    Int J Biochem Cell Biol; 2019 Nov; 116():105590. PubMed ID: 31442606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endoplasmic reticulum resident oxidase ERO1-Lalpha promotes hepatocellular carcinoma metastasis and angiogenesis through the S1PR1/STAT3/VEGF-A pathway.
    Yang S; Yang C; Yu F; Ding W; Hu Y; Cheng F; Zhang F; Guan B; Wang X; Lu L; Rao J
    Cell Death Dis; 2018 Oct; 9(11):1105. PubMed ID: 30377291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin E2 accelerates invasion by upregulating Snail in hepatocellular carcinoma cells.
    Zhang M; Zhang H; Cheng S; Zhang D; Xu Y; Bai X; Xia S; Zhang L; Ma J; Du M; Wang Y; Wang J; Chen M; Leng J
    Tumour Biol; 2014 Jul; 35(7):7135-45. PubMed ID: 24760275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MAT2B mediates invasion and metastasis by regulating EGFR signaling pathway in hepatocellular carcinoma.
    Wu L; Chen P; Ying J; Zhang Q; Liu F; Lv B; Che Z; Zhang W; Wu M; Zhang J; Yang D; Liu J
    Clin Exp Med; 2019 Nov; 19(4):535-546. PubMed ID: 31493275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. m
    Hu B; Gao J; Shi J; Wen P; Guo W; Zhang S
    Mol Carcinog; 2023 Oct; 62(10):1599-1614. PubMed ID: 37449789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.